276 related articles for article (PubMed ID: 37119510)
21. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
[TBL] [Abstract][Full Text] [Related]
22. [Role of suindac in the treatment of familial adenomatous polyposis coli].
Landauer S; Halimi C; Caulin C; Bergmann JF
Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
[TBL] [Abstract][Full Text] [Related]
23. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of colorectal neoplasia.
Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
[TBL] [Abstract][Full Text] [Related]
25. Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
Fornasarig M; Magris R; De Re V; Bidoli E; Canzonieri V; Maiero S; Viel A; Cannizzaro R
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882764
[TBL] [Abstract][Full Text] [Related]
26. [Genetic counseling, surgical prophylaxis and treatment for familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer].
Iarŭmov N; Toshev S; Petrova D; Angelov K; Gribnev P; Sokolov M
Khirurgiia (Sofiia); 2007; (3):46-53. PubMed ID: 18437111
[TBL] [Abstract][Full Text] [Related]
27. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
[TBL] [Abstract][Full Text] [Related]
28. [Hereditary colorectal cancer].
Park JG; Kim IJ
Korean J Gastroenterol; 2005 Feb; 45(2):78-87. PubMed ID: 15725711
[TBL] [Abstract][Full Text] [Related]
29. Biology of Precancers and Opportunities for Cancer Interception: Lesson from Colorectal Cancer Susceptibility Syndromes.
Monahan KJ; Swinyard O; Latchford A
Cancer Prev Res (Phila); 2023 Aug; 16(8):421-427. PubMed ID: 37001883
[TBL] [Abstract][Full Text] [Related]
30. Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.
Yamano T; Hamanaka M; Babaya A; Kimura K; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Matsubara N; Tomita N; Sugihara K
Cancer Sci; 2017 Feb; 108(2):243-249. PubMed ID: 27870147
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic Management and Surgical Considerations for Familial Adenomatous Polyposis.
Stanich PP; Sullivan B; Kim AC; Kalady MF
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):113-130. PubMed ID: 34798980
[TBL] [Abstract][Full Text] [Related]
32. Gastroduodenal lesions in familial adenomatous polyposis.
Kashiwagi H; Spigelman AD
Surg Today; 2000; 30(8):675-82. PubMed ID: 10955728
[TBL] [Abstract][Full Text] [Related]
33. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
Sangha S; Yao M; Wolfe MM
Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
[TBL] [Abstract][Full Text] [Related]
34. Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review.
Gao XH; Li J; Zhao ZY; Xu XD; Du YQ; Yan HL; Liu LJ; Bai CG; Zhang W
BMC Gastroenterol; 2020 Jun; 20(1):167. PubMed ID: 32487124
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
[TBL] [Abstract][Full Text] [Related]
36. Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance.
Gleeson FC; Papachristou GI; Riegert-Johnson DL; Boller AM; Gostout CJ
Fam Cancer; 2009; 8(1):33-8. PubMed ID: 18649121
[TBL] [Abstract][Full Text] [Related]
37. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome).
Smith KD; Rodriguez-Bigas MA
Surg Oncol Clin N Am; 2009 Oct; 18(4):705-15. PubMed ID: 19793576
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib as adjunctive therapy for treatment of colorectal cancer.
North GL
Ann Pharmacother; 2001 Dec; 35(12):1638-43. PubMed ID: 11793634
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy for inherited colorectal cancer.
Lynch PM
Expert Opin Pharmacother; 2010 May; 11(7):1101-8. PubMed ID: 20345333
[TBL] [Abstract][Full Text] [Related]
40. Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome.
Möslein G; Pistorius S; Saeger HD; Schackert HK
Langenbecks Arch Surg; 2003 Mar; 388(1):9-16. PubMed ID: 12690475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
